Aprepitant topical - LEO Pharma

Drug Profile

Aprepitant topical - LEO Pharma

Alternative Names: Aprepitant gel - LEO Pharma

Latest Information Update: 20 Feb 2016

Price : $50

At a glance

  • Originator LEO Pharma
  • Class Antidepressants; Antiemetics; Fluorobenzenes; Morpholines; Small molecules; Triazoles
  • Mechanism of Action Neurokinin 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Pruritus

Most Recent Events

  • 17 Apr 2016 Biomarkers information updated
  • 19 Feb 2016 No recent reports on development identified - Phase-II for Pruritus in Germany (Topical)
  • 01 Jul 2014 LEO Pharma completes the phase II iTAPP trial in Pruritus in Germany (NCT01963793)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top